Article
LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay.
Parkinsonism & related disorders - 1 Jun 2009
Mata Ignacio F, Cosentino Carlos, Marca Victoria, Torres Luis, Mazzetti Pilar, Ortega Olimpio, Raggio Victor, Aljanati Ruth, Buzó Ricardo, Yearout Dora, Dieguez Elena, Zabetian Cyrus P
Abstract excerpt
Variation in the leucine-rich repeat kinase 2 (LRRK2) gene represents the most common genetic determinant of Parkinson's disease (PD) identified to date. While the frequency and distribution of LRRK2 mutations have been well-studied in Europe and North America, few data are available from South America. To address this gap in knowledge, we screened two cohorts of patients with PD from Peru (n=240) and Uruguay...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
